Catalyst Wire Dossier Catalyst Wire Dossier

RDC-1036 (ALKS 37)

· Alkermes, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RDC-1036 (ALKS 37), covering 2011-08-23 to 2011-08-23. Get the full timeline:

Most recent: Clinical Trial Update: ALK37-003: A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation (OIC) [Phase 2]

See pricing